|
|
|
Immuno-Oncology 360 2028 |
|
| The Premier Meeting Across all Stakeholders in Immuno-Oncology |
| Dates:
TBD
|
| Venue: TBD,
TBD,
United States |
|
|
Where biotech and pharma leaders report on the latest advancements and data in Immuno-Oncology
IO360 brings together biotech, pharma, investors, academia, and solution providers to share data and report on the latest advancements in immuno-oncology. Our audience includes hundreds of biotech and pharma executives involved in immunotherapy drug development
C Level - CEO, CTO, CFO, Chief Business Officer, Chief Commercial Officer, Chief Medical Officer
Executive VPs, VPs, Senior Director/Directors
Managing Directors, Principals, Partners
Heads of Cancer Immunotherapy, R&D, Biomarkers, Translational Research, Assay Development, Diagnostics, Imaging, Gene Sequencing
|
Website: https://www.io360summit.com/
|
|
|
|
|